Home REVA Medical

REVA Medical

In operation
Post-IPO Round
Vascular Device Development and Manufacturing
Basic
Enterprise Profile

Basic Information

REVA Medical is a medical device company dedicated to developing bioresorbable polymers for vascular applications. Its mission is to restore lifelong health for patients by applying biomaterials in the development and commercialization of implantable medical devices. REVA’s lead product, Fantom Encore, is a drug-eluting bioresorbable scaffold for the treatment of coronary artery disease. Fantom Encore is made from REVA’s proprietary tyrosine-derived polymer, Tyrocore. Unlike metal stents, Fantom Encore is designed to support the artery through the healing process and then disappear from the body (or "resorb"), restoring the artery's natural function.
REVA Medical, LLC
SanDiego,California,United States of America
51~100 people
January 01, 1998
info@revamedical.com

Enterprise Profile

Industrial Sector
Medical Device R&D and Design
Concept
Cardiology Department Coronary Heart Disease Peripheral Vascular Disease
Application Scenarios
High-Value Medical Consumables Medical Device Consumables